ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RKVTF Rakovina Therapeutics Inc (PK)

0.08
0.00 (0.00%)
25 Nov 2024 - Closed
Delayed by 15 minutes

Rakovina Therapeutics (PK) Financial Summary

The current RKVTF market cap is 5.61M. The company's latest EPS is CAD -0.0373 and P/E is -5.36.

Year End 31 December 2023 2020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 0000
Operating Income -145k-2.06M-2.4M-2.17M
Net Income -191k-5.52M-2.79M-2.61M
Year End 31 December 2023 2020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 813k8.66M6.12M5.15M
Total Liabilities 42k114k107k1.49M
Total Equity 771k8.54M6.01M3.66M

Cash Flow

Year End 31 December 2023 2020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)
Operating -69k-2.31M-1.92M-1.86M
Investing 6k800k N/A N/A
Financing 397k4.32M2k1.4M
Market Cap 5.61M
Price to Earnings Ratio -5.36
Price to Sales Ratio 0
Price to Cash Ratio 32.26
Price to Book Ratio 3.83
Dividend Yield -

Share Statistics

Shares Outstanding 70.08M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change 33.33%
52 Week High 0.08
52 Week Low 0.06
Spread (Intraday) 0 (0%)

Company Info

Company Name Rakovina Therapeutics Inc (PK)
Address 720,999 west broadway
vancouver, british columbia V5Z1K5
Website https://www.rakovinatherapeutics.com
Industry unit inv tr, closed-end mgmt (6726)